All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

AKIN GUMP STRAUSS HAUER & FELD filed a Q2 report for UCB, INC. on July 20, 2026, reporting $80,000 in lobbying income.

Lobbying for UCB, INC. · Biopharmaceutical company

All filings by AKIN GUMP STRAUSS HAUER & FELD · Everything UCB, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Georgia

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Trade (domestic/foreign)

Issues related to global biopharmaceutical supply chains; Issues related to Section 232 investigations on pharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.